Josiane Parier
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Clinical Impact of Systemic Treatment Choices Made in Current Practice in Elderly Patients with Atopic Dermatitis.
Journal: Acta dermato-venereologica
Published: July 02, 2025
Effectiveness and Safety of Tralokinumab in Atopic Dermatitis: 1-year Results From a Real-world Multicentre Study.
Journal: Acta dermato-venereologica
Published: October 16, 2024
Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study).
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 25, 2024
Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm.
Journal: Annales de dermatologie et de venereologie
Published: June 27, 2023
Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
Journal: Acta dermato-venereologica
Published: June 12, 2023
Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 26, 2023
Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort - A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses.
Journal: Dermatology (Basel, Switzerland)
Published: March 24, 2023
A Multicentre Randomised Controlled Study Evaluating the Effect of a Standardised Education Programme on Quality of Life, Disease Severity, and Disease Knowledge in Patients with Moderate-To-Severe Psoriasis: The EDUPSO Study.
Journal: Dermatology (Basel, Switzerland)
Published: May 03, 2021
Use of Methotrexate in the Treatment of Moderate to Severe Plaque Psoriasis in France: A Practice Survey.
Journal: Clinical, cosmetic and investigational dermatology
Published: March 16, 2021
Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis.
Journal: Acta dermato-venereologica
Published: October 28, 2020
Real-World Effectiveness and Safety of Apremilast in Older Patients with Psoriasis.
Journal: Drugs & aging
Published: July 23, 2020
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: May 14, 2020
Last Updated: 09/26/2026